Home / Conferences / ACI 10th Annual Summit on Biosimilars 2019
ACI 10th Annual Summit on Biosimilars 2019 Posted 09/11/2018
10th Annual Summit on Biosimilars
24‒25 June 2019
New York City, NY, USA
ACI is proud to present a stellar speaking faculty consisting of top innovator and biosimilar makers, government representatives, and leading law firms as they discuss the hottest industry challenges and provide their skilled insights into the design and execution of successful biosimilars strategies. Network with leading counsel representing both biosimilar and innovator companies at the industry’s one and only event directed to the legal, regulatory and commercial aspects of the biosimilars marketplace. Visit our website, www.AmericanConference.com/Biosimilars, for more information and updates. Register today and get 10% off with promo code: P10-999-GBJ19.
Generics News Research General
- European regulatory framework for approval of b...Generics/Research | Posted 15/02/2019
- Safety surveillance of bevacizumab biosimilar (...Generics/Research | Posted 15/02/2019
- Impact of generic reference pricing on candesar...Generics/Research | Posted 15/02/2019
- Zydus gets FDA approval for skin, heart and aci...Generics/News | Posted 15/02/2019
Biosimilars News Research General
- Questions over DANBIO relevance for non-medical...Biosimilars/Research | Posted 22/02/2019
- EC approval for pegfilgrastim biosimilar FulphilaBiosimilars/News | Posted 22/02/2019
- EC approval for pegfilgrastim biosimilars Pelme...Biosimilars/News | Posted 30/11/2018
- Biosimilar teriparatide approved for the treatm...Biosimilars/Research | Posted 22/02/2019